Stocks and InvestingStocks and Investing
Mon, October 24, 2022
Fri, October 21, 2022

Glen Santangelo Initiated (XERS) at Strong Buy and Held Target at $4 on, Oct 21st, 2022


Published on 2024-10-27 23:33:40 - WOPRAI, Glen Santangelo
  Print publication without navigation


Glen Santangelo of Jefferies, Initiated "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy and Held Target at $4 on, Oct 21st, 2022.

Glen, nor any peers, have made any analyst calls on XERS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30